Alsanza Medizintechnik und Pharma GmbH proudly unveils the ALSEE Boost Preloaded and ALSEE Boost Toric Preloaded intraocular lenses (IOLs), marking a new milestone in extended depth of focus (EDOF) technology. These breakthrough lenses are designed to deliver an unparalleled visual experience, offering patients a continuous range of high-quality vision from far to intermediate distances, enhancing daily activities and reducing spectacle dependence.
These innovative IOLs are part of the ALSEE umbrella brand, which features 100% glistening-free hydrophobic material, ensuring long-term optical clarity and superior visual outcomes.
ALSEE Boost is a true EDOF IOL, featuring an addition of 2.0 D for extended intermediate vision with a patented optical design. This allows patients to achieve seamless and continuous high-quality vision from distance to intermediate and functional near vision, significantly improving everyday visual performance and reducing dependency on spectacles.
ALSEE Boost incorporates patented OptiWave Engineering, a revolutionary design that employs a phase-shifting surface to achieve EDOF. This advanced technology ensures an extended continuous focal range, optimizing light distribution for a smooth transition between far and intermediate vision.
The OptiWave Engineering phase-shifting surface provides a seamless transition between continuous far and extended intermediate vision. This smooth focal progression enables natural visual perception across distances, improving the overall patient experience.
Patients can experience high-quality vision across a range of distances, from far to intermediate. This seamless visual performance makes daily activities such as reading, working on digital screens, and driving more comfortable and enjoyable.
Unlike traditional multifocal IOLs, ALSEE Boost features a non-diffractive profile, reducing common visual disturbances such as halos and glare. This ensures patients experience monofocal-like contrast sensitivity and minimal dysphotopsia, delivering superior clarity across all distances.
The ALSEE Boost IOLs are available exclusively in a preloaded delivery system, making them exceptionally easy to use and comfortable for surgeons. This system simplifies implantation, reduces surgical time, and enhances procedural efficiency, leading to better patient outcomes.
Rigorous testing at Koç University's Optical Microsystems Laboratory confirmed ALSEE Boost’s outstanding performance. Using a state-of-the-art Holographic Vision Simulator, researchers confirmed the lens’s superior visual acuity, contrast sensitivity, and minimal halo severity. Simulations conducted under low-light conditions demonstrated no instances of glare, reinforcing the lens’s reliability across different lighting environments.
Alsanza successfully introduced the ALSEE Boost Preloaded and ALSEE Boost Toric Preloaded IOLs at the prestigious 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) 2024 in Barcelona. Held at Fira Barcelona Gran Via from September 6–10, the launch highlighted Alsanza’s unwavering commitment to advancing ophthalmic technology and improving patient care.
Headquartered in Pfullingen, Germany, Alsanza Medizintechnik und Pharma GmbH is dedicated to revolutionizing ophthalmic care through innovative medical technologies. With a strong focus on intraocular lenses and viscoelastics, Alsanza aims to contribute to advancements in eye care, supporting better patient outcomes and evolving industry standards.
For more information, visit www.alsanza.com.